Journal of Antimicrobial Chemotherapy
Journal Title
- Journal of Antimicrobial Chemotherapy
ISSN
- E 1460-2091 | P 0305-7453 | 1460-2091 | 0305-7453
Publisher
- Oxford University Press
- OUP
Listed on(Coverage)
| JCR | 1997-2019 |
|---|---|
| SJR | 1999-2019 |
| CiteScore | 2011-2019 |
| SCI | 2010-2019 |
| SCIE | 2010-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- The Journal publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, and articles in veterinary medicine likely to have an impact on global health. The Journal particularly welcomes manuscripts on: /// the practice of evidence-based medicine relating to antimicrobials (clinical trials, systematic reviews and meta-analyses) /// antimicrobial treatment (pharmacokinetics, pharmacodynamics and prescribing practices) /// the action of antimicrobial agents and the mechanisms, genetics and epidemiology of antimicrobial resistance /// antimicrobial stewardship /// the genetic basis of antimicrobial resistance /// In addition, the Journal is very keen to publish articles that: •offer evidence-based synthesis of knowledge and data useful for clinical practice /// analyse, reflect and comment on the current state of the art and practice /// consolidate our knowledge of antimicrobial agents and their use /// consider the future of antimicrobial chemotherapy The Journal will consider publishing articles on: /// new approaches to improving antimicrobial chemotherapy /// new compounds provided evidence is offered of selective antimicrobial activity and comparative cytotoxicity data /// previously unreported antimicrobial activity relating to a marketed drug product but such studies must take into account the exposure to the drug that can be safely achieved with clinically acceptable doses /// articles reporting the activity of bacteriophages The Journal will not usually consider publishing material on: /// the chemical synthesis or characterization of compounds. These are better suited to chemistry journals. /// the use and activity of biocides or disinfectants. These require specialist methodology and are generally better suited to more specialist journals. /// the process of turning antimicrobials into a medication i.e. pharmaceutics. These are better suited to a pharmacy journal /// drug stability studies /// naturally occurring substances or extracts that exhibit antimicrobial activity but for which no specific active ingredient has been chemically defined